Cargando…
Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection
Chronic hepatitis B virus (CHB) infection remains a major global public health issue for which there is still lacking effective curative treatment. Interferon-α (IFN-α) and its pegylated form have been approved as an anti-HBV drug with the advantage of antiviral activity and host immunity against HB...
Autores principales: | Wang, Jiayi, Du, Lingyao, Tang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651562/ https://www.ncbi.nlm.nih.gov/pubmed/34901094 http://dx.doi.org/10.3389/fmed.2021.784172 |
Ejemplares similares
-
Endoplasmic Reticulum Stress in Hepatitis B Virus and Hepatitis C Virus Infection
por: Hu, Tengyue, et al.
Publicado: (2022) -
Exosomal Interferon‐Induced Transmembrane Protein 2 Transmitted to Dendritic Cells Inhibits Interferon Alpha Pathway Activation and Blocks Anti–Hepatitis B Virus Efficacy of Exogenous Interferon Alpha
por: Shi, Ying, et al.
Publicado: (2019) -
Interferon-alpha responsible EPN3 regulates hepatitis B virus replication
por: Li, Xueqian, et al.
Publicado: (2022) -
An insight into the molecular characteristics of hepatitis C virus for clinicians
por: Du, Lingyao, et al.
Publicado: (2016) -
IFIT1 polymorphisms predict interferon-α treatment efficiency for hepatitis B virus infection
por: Xie, Dong-Ying, et al.
Publicado: (2016)